BERRY'S ARCTIC ICE, L.L.C.

BERRY'S ARCTIC ICE, L.L.C. specializes in the manufacturing and supply of dry ice for mission-critical federal applications, leveraging industrial gas manufacturing expertise to deliver solid carbon dioxide solutions under stringent operational conditions. Their technical focus centers on cryogenic material production, temperature-controlled logistics, and safe handling protocols for dry ice used in biosafety and research environments. The company demonstrates precision in meeting the thermal stability and purity requirements essential for laboratory and biocontainment operations, particularly in applications requiring sublimation-controlled environments. Their capability is distinguished by consistent adherence to federal specifications for non-toxic, residue-free cooling agents used in sensitive biological and diagnostic workflows. The contractor has delivered services to the U.S. Department of Agriculture, specifically supporting the National Bio and Agro-Defense Facility (NBAF), where dry ice is essential for sample preservation, pathogen transport, and cold chain integrity in high-containment research. This relationship suggests a focused engagement with federal agencies requiring secure, reliable cryogenic logistics for biosecurity and agricultural defense missions. The work implies deep familiarity with USDA’s biosafety level 3 and 4 operational standards and the regulatory frameworks governing hazardous material handling in federal laboratories. Operating under NAICS 325120, BERRY'S ARCTIC ICE, L.L.C. is positioned within the industrial gas manufacturing sector, with a narrow but highly specialized vertical in solid carbon dioxide production. This places them in a niche market serving federal research, veterinary pathology, and biocontainment facilities that require industrial-grade dry ice with consistent sublimation rates and purity certification. Their market positioning is that of a precision supplier rather than a broad-volume distributor, catering to mission-critical applications where material consistency is non-negotiable. As a small business structured as a 2K entity, the company operates from Topeka, Kansas, with no federal certifications publicly listed. Their geographic footprint is limited but strategically aligned with federal biodefense infrastructure, indicating a focused, capability-driven approach to government contracting rather than broad market expansion.